Inactive Instrument
Isodiol International Inc. Stock Canadian Securities Exchange
Stocks
ISOL
CA46500L2003
Pharmaceuticals
OTC Markets Traded| Market Cap | 3.91M 2.76M 2.42M 2.23M 2.09M 260M 3.99M 26.78M 10.36M 129M 10.35M 10.13M 446M | P/E 2018 |
-4.94x | P/E 2019 | -0.37x |
|---|---|---|---|---|---|
| Enterprise Value | 9.13M 6.44M 5.64M 5.2M 4.87M 607M 9.32M 62.53M 24.2M 300M 24.17M 23.64M 1.04B | EV / Sales 2018 |
12.6x | EV / Sales 2019 | 2.48x |
| Free-Float |
100% | Yield 2018 * |
-
| Yield 2019 | - |
| 1 day | +16.67% |
| Manager | Title | Age | Since |
|---|---|---|---|
Marcos Agramont
CEO | Chief Executive Officer | - | 2017-05-23 |
Andrew Alvis
DFI | Director of Finance/CFO | - | - |
| Corporate Officer/Principal | - | 2018-08-29 |
| Director | Title | Age | Since |
|---|---|---|---|
Marcos Agramont
BRD | Director/Board Member | - | 2017-05-23 |
| Director/Board Member | - | 2018-08-29 | |
| Director/Board Member | - | 2018-11-20 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +16.67% | +40.00% | - | - | 128 | |
| -0.32% | -2.95% | -15.89% | -9.14% | 12.33B | |
| -2.14% | -4.72% | -38.81% | -59.95% | 4.51B | |
| -0.57% | -4.82% | -17.28% | -8.94% | 4.11B | |
| -3.74% | -2.40% | +4.56% | -43.07% | 3.6B | |
| -3.92% | -6.18% | +6.51% | -21.41% | 3.58B | |
| -1.01% | -1.97% | -12.32% | -10.06% | 3.44B | |
| -2.50% | -6.03% | -15.56% | -5.83% | 2.91B | |
| -4.14% | -5.96% | -11.08% | -28.08% | 2.23B | |
| 0.00% | -3.73% | -14.63% | +24.81% | 1.6B | |
| Average | -0.17% | -3.70% | -12.72% | -17.96% | 4.26B | |
| Weighted average by Cap. | -1.66% | -3.69% | -14.05% | -18.95% |
| 2018 | 2019 | |
|---|---|---|
| Net sales | 19.14M 13.49M 11.83M 10.9M 10.21M 1.27B 19.53M 131M 50.7M 629M 50.65M 49.54M 2.18B | 22.25M 15.68M 13.75M 12.67M 11.86M 1.48B 22.71M 152M 58.94M 731M 58.88M 57.59M 2.53B |
| Net income | -36.02M -25.39M -22.26M -20.52M -19.21M -2.39B -36.77M -247M -95.43M -1.18B -95.33M -93.25M -4.1B | -126M -88.74M -77.81M -71.72M -67.15M -8.37B -129M -862M -334M -4.14B -333M -326M -14.35B |
| Net Debt | -15.55M -10.96M -9.61M -8.86M -8.29M -1.03B -15.87M -106M -41.19M -511M -41.15M -40.25M -1.77B | 5.22M 3.68M 3.23M 2.97M 2.78M 347M 5.33M 35.75M 13.83M 172M 13.82M 13.52M 595M |
Employees
-
Sector
Pharmaceuticals
